ES507638A0 - Un metodo para preparar derivados de 1-sulfo-2-oxoazetidina . - Google Patents

Un metodo para preparar derivados de 1-sulfo-2-oxoazetidina .

Info

Publication number
ES507638A0
ES507638A0 ES507638A ES507638A ES507638A0 ES 507638 A0 ES507638 A0 ES 507638A0 ES 507638 A ES507638 A ES 507638A ES 507638 A ES507638 A ES 507638A ES 507638 A0 ES507638 A0 ES 507638A0
Authority
ES
Spain
Prior art keywords
sulfo
preparing
oxoazetidine derivatives
oxoazetidine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES507638A
Other languages
English (en)
Other versions
ES8303327A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ES507638A0 publication Critical patent/ES507638A0/es
Publication of ES8303327A1 publication Critical patent/ES8303327A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES507638A 1980-12-03 1981-12-02 Un metodo para preparar derivados de 1-sulfo-2-oxoazetidina . Expired ES8303327A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1980/000293 WO1982001871A1 (en) 1980-12-03 1980-12-03 Process for preparing a 1-sulfo-2-oxoazetidine derivative

Publications (2)

Publication Number Publication Date
ES507638A0 true ES507638A0 (es) 1983-02-01
ES8303327A1 ES8303327A1 (es) 1983-02-01

Family

ID=13706129

Family Applications (1)

Application Number Title Priority Date Filing Date
ES507638A Expired ES8303327A1 (es) 1980-12-03 1981-12-02 Un metodo para preparar derivados de 1-sulfo-2-oxoazetidina .

Country Status (5)

Country Link
EP (1) EP0053387A1 (es)
JP (1) JPS57118560A (es)
DK (1) DK534281A (es)
ES (1) ES8303327A1 (es)
WO (1) WO1982001871A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342929A1 (de) * 1983-11-26 1985-06-05 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zu deren herstellung sowie ihre verwendung als arzneimittel
US4883869A (en) * 1984-12-20 1989-11-28 The Upjohn Company Novel beta-lactams containing amino acid substituents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
US4224336A (en) * 1979-04-17 1980-09-23 Merck & Co., Inc. 3-(2-Aminoethylthio)-6-amido-7-oxo-1-azabicyclo[3.2.0]-hept-2-ene-2-carboxylic acid
CA1338538C (en) * 1979-06-08 1996-08-20 Taisuke Matsuo 1-sulfo-2-oxoazetidine derivatives and their production

Also Published As

Publication number Publication date
WO1982001871A1 (en) 1982-06-10
JPS57118560A (en) 1982-07-23
EP0053387A1 (en) 1982-06-09
DK534281A (da) 1982-06-04
ES8303327A1 (es) 1983-02-01

Similar Documents

Publication Publication Date Title
ES505373A0 (es) Un metodo para preparar derivados de fenilpiperazina
ES520104A0 (es) Un procedimiento para preparar derivados de nicotinamida.
ES530391A0 (es) Un metodo para preparar derivados de 4-hidroxi-2-quinolona.
ES507065A0 (es) Un metodo para preparar derivados de 2-oxoazetidina.
ES530017A0 (es) Un metodo para preparar derivados de 3-metilflavona
ES527304A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES505656A0 (es) Un procedimiento para preparar nuevos derivados de antraci- clina
ES521361A0 (es) Un metodo para preparar un derivado 14-acilico de lankacidina.
ES507975A0 (es) Un metodo para preparar derivados de pirazolina.
ES502026A0 (es) Un procedimiento para preparar derivados de tetrazolilcuma- rina
ES521389A0 (es) Un metodo para preparar derivados de tiazolidina.
ES519936A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES527705A0 (es) Un metodo para preparar derivados de fenotiazina
ES522716A0 (es) Un procedimiento para preparar un derivado de pirazol.
ES538036A0 (es) Un procedimiento para preparar derivados de piridona.
ES506930A0 (es) Un procedimiento para preparar derivados de n-fenil-dicloro-maleimida.
ES506970A0 (es) Un metodo mejorado para producir un compuesto de 7-aminoce- fem.
ES508928A0 (es) Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos.
ES506302A0 (es) Un procedimiento para preparar derivados de tetrahidroiso- quinoleinas
ES538032A0 (es) Un procedimiento para preparar derivados de isoxazolamina.
ES507638A0 (es) Un metodo para preparar derivados de 1-sulfo-2-oxoazetidina .
ES518580A0 (es) Un procedimiento para preparar un derivado de aminopropilaminobleomicina.
ES520370A0 (es) Un procedimiento para obtener derivados de isoxazolopirimidina.
ES501282A0 (es) Un metodo para obtener 2,6-diaminonebularinas
ES538037A0 (es) Un procedimiento para preparar derivados de pirazinona.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010301